Compugen Sells Two More Bioinformatics Platforms to Monsanto | GenomeWeb

WOBURN, Mass.--Israeli bioinformatics company Compugen, whose worldwide sales office is based here, has installed two additional high-throughput sequence analysis and bioinformatics platforms for Monsanto. Two BioXL/P-12 accelerators and associated GenCore and GenWeb software components will allow Monsanto to "add similarity annotation to genetic sequence data in an accurate and facile manner," according to Harry Harlow, Monsanto's director of bioinformatics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.